Gloucester Pharmaceuticals Inc — Form D
Gloucester Pharmaceuticals Inc of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-21. The offering totals $28.9M, of which $20.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-08-21
- Form: D
- Accession: 0001307826-09-000009
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $28.9M
- Amount sold: $20.3M
- Remaining: $8.6M
- Investors: 9
- Date of first sale: 2009-08-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-70770
Issuer
- Name: Gloucester Pharmaceuticals Inc
- CIK: 0001307826
- Entity type: Corporation
- Jurisdiction: DE
- Address: 1 BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-583-1300
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Alan B Colowick | Director | South San Francisco, CA |
| THOMAS DYRBERG | Director | CAMBRIDGE, MA |
| Seth Harrison | Director | Redwood City, CA |
| Donald J Hayden | Director | Cranbury, NJ |
| Jay Moorin | Director | New York, NY |
| David Schnell | Director | New York, NY |
| Martin Vogelbaum | Director | New York, NY |
| Alan B Colowick | Executive Officer | South San Francisco, CA |
| Donald J Hayden | Executive Officer | Cranbury, NJ |
| Jean C Nichols | Executive Officer | Cambridge, MA |
| Nicholas Vrolijk | Executive Officer | Cambridge, MA |
Other filings by this issuer (5)
More